Actively Recruiting
Feasibility and Safety Study of Intratumoral Alpha Radiation Device for Advanced Pancreatic Cancer Treatment
Led by Alpha Tau Medical LTD. · Updated on 2026-06-16
15
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates a novel method for treating locally advanced pancreatic cancer using an intratumoral diffusing alpha radiation emitter device. The study aims to evaluate the feasibility and safety of this approach in patients whose cancer is not suitable for surgery or further chemotherapy. It is a prospective, single-center, open-label, single-arm trial designed to provide insight into this new treatments potential. Participants will undergo a procedure where radioactive seeds containing Ra-224 are inserted directly into the tumor. These seeds release alpha-emitting atoms within the tumor to target the cancer cells. The study includes a screening period, the DaRT seed insertion visit, followed by a 3-month follow-up for each patient. The overall trial duration is planned for 24 months, including patient recruitment and study completion. Throughout the study, participants will be closely monitored with safety assessments focusing on adverse events immediately after the insertion and up to 48 hours later. Researchers will also evaluate treatment efficacy by measuring tumor response and tumor marker levels at 1 and 3 months. The study involves imaging and laboratory tests to assess tumor size and coverage by the seeds. Participants will be observed for treatment safety and feasibility, contributing to knowledge about this innovative therapys role in managing advanced pancreatic cancer.
CONDITIONS
Brief Title
Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer
Research Team
L
Liron Dimnik
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here